Stay updated on Efficacy and Safety of Cenobamate Adjunctive Therapy in POS Clinical Trial
Sign up to get notified when there's something new on the Efficacy and Safety of Cenobamate Adjunctive Therapy in POS Clinical Trial page.

Latest updates to the Efficacy and Safety of Cenobamate Adjunctive Therapy in POS Clinical Trial page
- Check5 days agoChange DetectedFooter now displays 'Revision: v3.3.3'. The earlier 'HHS Vulnerability Disclosure' item and 'Revision: v3.3.2' have been removed.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe Publications section now states that items are auto-filled from PubMed and may not be about the study, and the page revision label was updated to v3.3.2.SummaryDifference0.1%

- Check33 days agoChange DetectedThe government funding/operating status notice that previously appeared on the page was removed, eliminating details about potential delays and NIH Clinical Center operations.SummaryDifference0.4%

- Check48 days agoChange DetectedAdded a Last known status block to the study record showing sponsor SK Life Science, Inc., date 2023-10, and verification status.SummaryDifference0.4%

- Check55 days agoChange DetectedThe updates seem to be superficial UI changes (cookie banner and header/footer adjustments) with no alterations to the study's design, eligibility criteria, primary outcome measures, or enrollment information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check63 days agoChange DetectedAdded a new Publications section featuring a specific PubMed-listed study on cenobamate efficacy in focal seizure subtypes; no deletions were made. This expands authoritative sources on the page.SummaryDifference4%

Stay in the know with updates to Efficacy and Safety of Cenobamate Adjunctive Therapy in POS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy and Safety of Cenobamate Adjunctive Therapy in POS Clinical Trial page.